{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:30:58Z","timestamp":1772109058058,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,29]]},"DOI":"10.7759\/cureus.47936","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T06:55:47Z","timestamp":1698648947000},"source":"Crossref","is-referenced-by-count":2,"title":["Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy"],"prefix":"10.7759","author":[{"given":"Rasim","family":"Meral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem S","family":"Selcukbiricik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse K","family":"Uzum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Okutan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Barburoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyas","family":"Dolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa","family":"Altun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Yarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Kad\u0131oglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12112","article-title":"Emerging trends in the diagnosis and treatment of acromegaly in Canada","volume":"79","author":"Vallette S","year":"2013","unstructured":"Vallette S, Ezzat S, Chik C, et al.. Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol (Oxf). 2013, 79:79-85. 10.1111\/cen.12112","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1696724","article-title":"Factors associated with and temporal trends in the use of radiation therapy for the treatment of pituitary adenoma in the National Cancer Database","volume":"82","author":"Fathy R","year":"2021","unstructured":"Fathy R, Kuan E, Lee JY, et al.. Factors associated with and temporal trends in the use of radiation therapy for the treatment of pituitary adenoma in the National Cancer Database. J Neurol Surg B Skull Base. 2021, 82:285-94. 10.1055\/s-0039-1696724","journal-title":"J Neurol Surg B Skull Base"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12207","article-title":"Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists","volume":"79","author":"Howlett TA","year":"2013","unstructured":"Howlett TA, Willis D, Walker G, Wass JA, Trainer PJ. Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists. Clin Endocrinol (Oxf). 2013, 79:689-99. 10.1111\/cen.12207","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.10.029","article-title":"Endoscopic endonasal versus microsurgical transsphenoidal approach for growth hormone-secreting pituitary adenomas\u2014systematic review and meta-analysis","volume":"97","author":"Phan K","year":"2017","unstructured":"Phan K, Xu J, Reddy R, Kalakoti P, Nanda A, Fairhall J. Endoscopic endonasal versus microsurgical transsphenoidal approach for growth hormone-secreting pituitary adenomas\u2014systematic review and meta-analysis. World Neurosurg. 2017, 97:398-406. 10.1016\/j.wneu.2016.10.029","journal-title":"World Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2021.07.018","article-title":"Final outcome in growth hormone-secreting adenomas after combination of maximal tumor resection and medical treatment","volume":"154","author":"Torres A","year":"2021","unstructured":"Torres A, Sanmillan JL, Lau R, Gabarros A. Final outcome in growth hormone-secreting adenomas after combination of maximal tumor resection and medical treatment. World Neurosurg. 2021, 154:e292-301. 10.1016\/j.wneu.2021.07.018","journal-title":"World Neurosurg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed S","year":"2009","unstructured":"Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009, 119:3189-202. 10.1172\/JCI39375","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson L","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:3933-51. 10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2004.04.011","article-title":"Basic principles of radiobiology, radiotherapy, and radiosurgery","volume":"15","author":"Shrieve DC","year":"2004","unstructured":"Shrieve DC, Klish M, Wendland MM, Watson GA. Basic principles of radiobiology, radiotherapy, and radiosurgery. Neurosurg Clin N Am. 2004, 15:467-79, x. 10.1016\/j.nec.2004.04.011","journal-title":"Neurosurg Clin N Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02199.x","article-title":"The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas","volume":"62","author":"Minniti G","year":"2005","unstructured":"Minniti G, Jaffrain-Rea ML, Osti M, et al.. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf). 2005, 62:210-6. 10.1111\/j.1365-2265.2005.02199.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4158\/EP15830.OR","article-title":"High-precision conformal fractionated radiotherapy is effective in achieving remission in patients with acromegaly after failed transsphenoidal surgery","volume":"22","author":"Patt H","year":"2016","unstructured":"Patt H, Jalali R, Yerawar C, et al.. High-precision conformal fractionated radiotherapy is effective in achieving remission in patients with acromegaly after failed transsphenoidal surgery. Endocr Pract. 2016, 22:162-72. 10.4158\/EP15830.OR","journal-title":"Endocr Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194998","article-title":"Gamma knife radiosurgery for pituitary tumors: a systematic review and meta-analysis","volume":"13","author":"Albano L","year":"2021","unstructured":"Albano L, Losa M, Barzaghi LR, et al.. Gamma knife radiosurgery for pituitary tumors: a systematic review and meta-analysis. Cancers (Basel). 2021, 13:10.3390\/cancers13194998","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2007.106.5.833","article-title":"Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission","volume":"106","author":"Pollock BE","year":"2007","unstructured":"Pollock BE, Jacob JT, Brown PD, Nippoldt TB. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg. 2007, 106:833-8. 10.3171\/jns.2007.106.5.833","journal-title":"J Neurosurg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0135","article-title":"The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma","volume":"93","author":"Losa M","year":"2008","unstructured":"Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, Mortini P. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab. 2008, 93:2546-52. 10.1210\/jc.2008-0135","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2009.45.3.157","article-title":"Stereotactic radiosurgery with the CyberKnife for pituitary adenomas","volume":"45","author":"Cho CB","year":"2009","unstructured":"Cho CB, Park HK, Joo WI, Chough CK, Lee KJ, Rha HK. Stereotactic radiosurgery with the CyberKnife for pituitary adenomas. J Korean Neurosurg Soc. 2009, 45:157-63. 10.3340\/jkns.2009.45.3.157","journal-title":"J Korean Neurosurg Soc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-016-2105-1","article-title":"Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus","volume":"128","author":"Iwata H","year":"2016","unstructured":"Iwata H, Sato K, Nomura R, et al.. Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus. J Neurooncol. 2016, 128:267-75. 10.1007\/s11060-016-2105-1","journal-title":"J Neurooncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0784","article-title":"Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry","volume":"182","author":"Knappe UJ","year":"2020","unstructured":"Knappe UJ, Petroff D, Quinkler M, et al.. Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry. Eur J Endocrinol. 2020, 182:275-84. 10.1530\/EJE-19-0784","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0610-1","article-title":"Long-term results of fractionated stereotactic radiotherapy as third-line treatment in acromegaly","volume":"50","author":"Diallo AM","year":"2015","unstructured":"Diallo AM, Colin P, Litre CF, et al.. Long-term results of fractionated stereotactic radiotherapy as third-line treatment in acromegaly. Endocrine. 2015, 50:741-8. 10.1007\/s12020-015-0610-1","journal-title":"Endocrine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.01.053","article-title":"Single-and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways","volume":"110","author":"Milano MT","year":"2021","unstructured":"Milano MT, Grimm J, Soltys SG, et al.. Single-and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways. Int J Radiat Oncol Biol Phys. 2021, 110:87-99. 10.1016\/j.ijrobp.2018.01.053","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6838.1343","article-title":"Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma","volume":"304","author":"Brada M","year":"1992","unstructured":"Brada M, Ford D, Ashley S, et al.. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ. 1992, 304:1343-6. 10.1136\/bmj.304.6838.1343","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00160-7","article-title":"Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance","volume":"10","author":"Hamblin R","year":"2022","unstructured":"Hamblin R, Vardon A, Akpalu J, et al.. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol. 2022, 10:581-8. 10.1016\/S2213-8587(22)00160-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref21","unstructured":"Macrotrends. Turkey death rate 1950-2023. (2022). Accessed: November 4, 2022: https:\/\/www.macrotrends.net\/countries\/TUR\/turkey\/death-rate."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione L","year":"2019","unstructured":"Maione L, Chanson P. National acromegaly registries. Best Pract Res Clin Endocrinol Metab. 2019, 33:101264. 10.1016\/j.beem.2019.02.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000095531","article-title":"Cancers associated with acromegaly","volume":"83","author":"Jenkins PJ","year":"2006","unstructured":"Jenkins PJ. Cancers associated with acromegaly. Neuroendocrinology. 2006, 83:218-23. 10.1159\/000095531","journal-title":"Neuroendocrinology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2793-9","article-title":"CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center\u2019s experience","volume":"138","author":"Sala E","year":"2018","unstructured":"Sala E, Moore JM, Amorin A, et al.. CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center\u2019s experience. J Neurooncol. 2018, 138:291-8. 10.1007\/s11060-018-2793-9","journal-title":"J Neurooncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3171\/2021.2.JNS204440","article-title":"Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations","author":"Mathieu D","year":"2021136","unstructured":"Mathieu D, Kotecha R, Sahgal A, et al.. Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations. J. Neurosurg. 2021136, 801-12. 10.3171\/2021.2.JNS204440","journal-title":"J. Neurosurg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-014-0802-2","article-title":"Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy","volume":"91","author":"Bostr\u00f6m JP","year":"2015","unstructured":"Bostr\u00f6m JP, Kinfe T, Meyer A, et al.. Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy. Strahlenther Onkol. 2015, 91:477-85. 10.1007\/s00066-014-0802-2","journal-title":"Strahlenther Onkol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2013.01.127","article-title":"Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report","volume":"82","author":"Grant RA","year":"2014","unstructured":"Grant RA, Whicker M, Lleva R, Knisely JP, Inzucchi SE, Chiang VL. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report. World Neurosurg. 2014, 82:195-201. 10.1016\/j.wneu.2013.01.127","journal-title":"World Neurosurg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14346","article-title":"Gamma Knife radiosurgery for acromegaly: Evaluating the role of the biological effective dose associated with endocrine remission in a series of 42 consecutive cases","volume":"94","author":"Balossier A","year":"2021","unstructured":"Balossier A, Tuleasca C, Cortet\u2010Rudelli C, Soto\u2010Ares G, Levivier M, Assaker R, Reyns N. Gamma Knife radiosurgery for acromegaly: Evaluating the role of the biological effective dose associated with endocrine remission in a series of 42 consecutive cases. Clin Endocrinol (Oxf). 2021, 94:424-33. 10.1111\/cen.14346","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2021.08.021","article-title":"Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35 Gy in 5 fractions","volume":"26","author":"Sumodhee S","year":"2022","unstructured":"Sumodhee S, Atallah V, Kinj R, et al.. Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35 Gy in 5 fractions. Cancer Radiother. 2022, 26:557-62. 10.1016\/j.canrad.2021.08.021","journal-title":"Cancer Radiother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178583-promising-outcomes-in-acromegaly-patients-receiving-cyberknife-stereotactic-hypofractionated-radiotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:16Z","timestamp":1707509356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178583-promising-outcomes-in-acromegaly-patients-receiving-cyberknife-stereotactic-hypofractionated-radiotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.47936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,29]]}}}